Market Overview

UPDATE: Merck Posts Upbeat Q3 Profit

Share:
Related MRK
Fast Money Halftime Report Final Trade From January 27
White House Budget To Support Biotech Rally
Foreign Currency Headwinds Take The Spotlight In Drug Maker Earnings (Seeking Alpha)

Merck & Co (NYSE: MRK) reported a drop in its third-quarter profit.

Merck's quarterly profit declined to $1.12 billion, or $0.38 per share, down from $1.73 billion, or $0.56 per share, in the year-earlier quarter. Its adjusted earnings fell to $0.92 per share from $0.95 per share.

Its sales dropped to $11.03 billion from $11.49 billion. However, analysts were estimating earnings of $0.87 per share on revenue of $11.1 billion.

Merck now expects 2013 adjusted earnings of $3.48 to $3.52 per share, versus its earlier forecast of $3.45 to $3.55 per share.

Merck shares gained 1.53% to $47.25 in pre-market trading.

Posted-In: profitEarnings News Guidance

 

Related Articles (MRK)

Around the Web, We're Loving...

Get Benzinga's Newsletters